OMEROS CORP Income Taxes Paid
OMEROS CORP (OMER) reported Income Taxes Paid of $501.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-12
- OMEROS CORP income taxes paid, net for the quarter ending 2026-06-30 was $444.00K, a 143.96% increase year-over-year.
- OMEROS CORP income taxes paid, net for the quarter ending 2026-03-31 was $57.00K.
- OMEROS CORP income taxes paid, net for the quarter ending 2025-12-31 was -$29.00K, a 110.58% decline year-over-year.
- OMEROS CORP income taxes paid, net for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- OMEROS CORP income taxes paid, net for fiscal 2025 was $153.00K, a 7.27% decline from fiscal 2024.
- OMEROS CORP income taxes paid, net for fiscal 2024 was $165.00K, a 94.99% decline from fiscal 2023.
- OMEROS CORP income taxes paid, net for fiscal 2023 was $3.29M, a 4015.00% increase from fiscal 2022.
- OMEROS CORP income taxes paid, net for fiscal 2022 was $80.00K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $444.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $501.00K 10-Q · filed 2026-08-12 | $472.00K derived: sum of 3 quarters · filed 2026-08-12 | $472.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $57.00K 10-Q · filed 2026-05-13 | $28.00K derived: sum of 2 quarters · filed 2026-05-13 | $28.00K derived: sum of 3 quarters · filed 2026-05-13 | $210.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$29.00K derived: sum of 2 quarters · filed 2026-03-31 | $153.00K derived: sum of 3 quarters · filed 2026-08-12 | $153.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $182.00K derived: sum of 2 quarters · filed 2026-08-12 | $182.00K 10-Q · filed 2025-11-13 | $456.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $182.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $182.00K 10-Q · filed 2026-08-12 | $456.00K derived: sum of 3 quarters · filed 2026-08-12 | $491.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 | $274.00K derived: sum of 2 quarters · filed 2026-05-13 | $309.00K derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-31 | $274.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $309.00K derived: sum of 2 quarters · filed 2026-03-31 | $165.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$109.00K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | -$144.00K 10-Q · filed 2025-08-14 | |||
| 2023-12-31 | -$484.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$484.00K derived: sum of 2 quarters · filed 2026-03-31 | $3.29M 10-K · filed 2026-03-31 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $3.78M 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $3.78M 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | $80.00K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |